Our Mission
The Oxford Vaccine Group has been at the forefront of vaccine development for 30 years, helping to fight diseases of major global importance through research and education around the world.
What's Happening?
Study Spotlight
🌍 Malaria remains a global health challenge with 240 million cases and 627,000 deaths in 2020. But we're on a mission to change this. Be part of the battle against Malaria!
| BIO-004👤 Healthy adults aged 18-45 📅 50 to 85 visits over 20 months 💉1 vaccination + 3 Malaria challenges 🧬 Understanding how the immune system responds to repeated malaria infections 🪙 Reimbursement: Between £8,740 to £9,100 (Depending on group) |
Be a Vaccine Hero
Take part in a study
Could you be a Vaccine Hero by taking part in one of our clinical trials? Find out about the trials and studies currently looking for volunteers, as well as what it is like taking part from previous participants.
Study - STELLAR
Can your child help vaccine research? Calling Tiny Heroes: Join The STELLAR Study for Better Nose Vaccines!
Study - RESPECCT
A challenge study to investigate RSV and SPN co-infection to understand how these two common germs alter the nose environment and impact human health.
Study - MAGIC-01
A study of a new vaccine against Marburg Virus
Research at OVG
Education, Learning and Public Involvement
Latest Publications
⠀⠀⠀⠀⠀
-
Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved.
Journal article
Aksöz M. et al, (2024), Sci Immunol, 9
-
RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding.
Journal article
Mitsi E. et al, (2024), Cell Host Microbe
-
Pandemic Preparedness: Why Humanities and Social Sciences Matter
Journal article
FRAMPTON S. et al, (2024), Frontiers in Public Health
-
Mayaro Virus: An Emerging Alphavirus in the Americas.
Journal article
Wei LLL. et al, (2024), Viruses, 16
Working Together
OVG is proud to lead the National Immunisation Schedule Evaluation Consortium II (NISEC II), a collaboration between a network of Academic Clinical Research groups and the UK Health Security Agency.
